Conversely, CSF3R mutations are less frequent in aCML, being found in < 10% of patients, and are rare in MDS/MPN-U [2,8,27]. This evidence concerns the gene CSF3R and atypical chronic myeloid leukemia, BCR-ABL1 negative.